Astellas Pharma Competitors and Similar CompaniesClear all

Astellas Pharma's competitors and similar companies include Pfizer, Bayer, Immunomedics, Urovant Sciences, Hetero and Viatris.
Astellas Pharma
Astellas Pharma
Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions.
Pfizer
Pfizer
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
Bayer
Bayer
Bayer is a life sciences company specializing in healthcare and nutrition.
Immunomedics
Immunomedics
Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer.
Urovant Sciences
Urovant Sciences
Urovant Sciences is a biopharmaceutical company focused on developing novel therapies for urologic conditions.
Hetero
Hetero
Hetero is a generic pharmaceutical company engaged in the development, manufacturing, and marketing of chemical and biologic drugs.
Viatris
Viatris
Viatris is a pharmaceutical company that develops and manufactures branded and generic medicines, biosimilar medicines, and over-the-counter products.
Founding Date
Founding Date
1923
Founding Date
1849
Founding Date
1863
Founding Date
1982
Founding Date
2016
Founding Date
1993
Founding Date
2020
Type
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Tokyo, JP HQ
Macquarie Park, AU
Wien, AT
Vilvoorde, BE
São Paulo, BR
Markham, CA
Beijing, CN
see more
Locations
New York, US HQ
Buenos Aires, AR
Villa Adelina, AR
Bentley, AU
Footscray, AU
Mulgrave, AU
Sydney, AU
see more
Locations
Leverkusen, DE HQ
Tirana, AL
Dely Ibrahim, DZ
Luanda, AO
Munro, AR
Pymble, AU
Wien, AT
see more
Locations
Morris Plains, US HQ
Locations
Irvine, US HQ
Basel, CH
Locations
Hyderabad, IN HQ
Norwest, AU
Sao Paulo, BR
Beijing, CN
Nanjing Shi, CN
Nanjing Shi, CN
Bogotá, CO
see more
Locations
Canonsburg, US HQ
Carole Park, AU
Millers Point, AU
Campos Dos Goytacazes, BR
São Paulo, BR
Sofia, BG
Toronto, CA
see more
Employees
Employees
14,484
Employees
83,0005% increase
Employees
99,7231% decrease
Employees
1061% decrease
Employees
3950% increase
Employees
21,000
Employees
38,0003% increase
Valuation ($)
Valuation ($)
17.5 b
Valuation ($)
163.3 b
Valuation ($)
31.3 b
Valuation ($)
N/A
Valuation ($)
531.8 m
Valuation ($)
N/A
Valuation ($)
12.5 b
Twitter followers
Twitter followers
50.4 k
Twitter followers
491.8 k
Twitter followers
184.4 k
Twitter followers
568
Twitter followers
221
Twitter followers
920
Twitter followers
8.3 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
25
Number of tweets (last 30 days)
16
Number of tweets (last 30 days)
30
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
4
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
5.8
Average likes per tweet (last 30 days)
63.4
Average likes per tweet (last 30 days)
10
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
3
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
9
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
96%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
73.33%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%

Financial

Revenue (est.)
Revenue (est.)
¥1.5t (FY, 2023)
Revenue (est.)
$58.5b (FY, 2023)
Revenue (est.)
€47.6b (FY, 2023)
Revenue (est.)
$295k (FY, 2019)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$15.4b (FY, 2023)
Cost of goods
Cost of goods
¥182.6b (FY, 2023)
Cost of goods
$25b (FY, 2023)
Cost of goods
€7b (FY, 2023)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$9b (FY, 2023)
Gross profit
Gross profit
¥1.3t (FY, 2023)
Gross profit
$33.5b (FY, 2023)
Gross profit
€42.1b (FY, 2023)
Gross profit
$295k (FY, 2019)
Gross profit
N/A
Gross profit
N/A
Gross profit
$6.4b (FY, 2023)
Net income
Net income
¥98.7b (FY, 2023)
Net income
$2.2b (FY, 2023)
Net income
(€2.9b) (FY, 2023)
Net income
($357.3m) (FY, 2019)
Net income
($146.7m) (FY, 2020)
Net income
N/A
Net income
$54.7m (FY, 2023)

Operating

Countries
Countries
N/A
Countries
125 (FY, 2021)
Countries
83 (FY, 2021)
Countries
N/A
Countries
N/A
Countries
126 (Jan, 2021)
Countries
165 (Q1, 2023)
Manufacturing Sites
Manufacturing Sites
N/A
Manufacturing Sites
39 (FY, 2021)
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
40 (Q1, 2023)
Patent Applications (US)
Patent Applications (US)
N/A
Patent Applications (US)
N/A
Patent Applications (US)
N/A
Patent Applications (US)
230 (Sep, 2022)
Patent Applications (US)
N/A
Patent Applications (US)
23 (Jan, 2021)
Patent Applications (US)
N/A
Patents (US)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
405 (Sep, 2022)
Patents (US)
N/A
Patents (US)
38 (Jan, 2021)
Patents (US)
N/A
Products
Products
N/A
Products
N/A
Products
N/A
Products
N/A
Products
N/A
Products
200 (Jan, 2021)
Products
4 (FY, 2022)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 3.5b
Total funding raised
$ 30m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Pfizer
HQ
New York, US
Employees
83,000↑ 5% increase

Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.

View company
Bayer
HQ
Leverkusen, DE
Employees
99,723↓ 1% decrease

Bayer is a life sciences company specializing in healthcare and nutrition.

View company
Immunomedics
HQ
Morris Plains, US

Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer.

View company
Urovant Sciences
HQ
Irvine, US
Employees
39↑ 50% increase

Urovant Sciences is a biopharmaceutical company focused on developing novel therapies for urologic conditions.

View company